[go: up one dir, main page]

ES8606297A1 - Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas - Google Patents

Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas

Info

Publication number
ES8606297A1
ES8606297A1 ES549920A ES549920A ES8606297A1 ES 8606297 A1 ES8606297 A1 ES 8606297A1 ES 549920 A ES549920 A ES 549920A ES 549920 A ES549920 A ES 549920A ES 8606297 A1 ES8606297 A1 ES 8606297A1
Authority
ES
Spain
Prior art keywords
tetrahydroimidazo
oxo
alkyl
quinnazolinyl
oxyalkylamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549920A
Other languages
English (en)
Other versions
ES549920A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES549920A0 publication Critical patent/ES549920A0/es
Publication of ES8606297A1 publication Critical patent/ES8606297A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR A LAS (2-OXO-1,2,3,5-TETRAHIDROIMIDAZO(2,1-B)QUINAZOLINIL)-OXIALQUILAMIDAS Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. COMPRENDE A) CICLAR A UN C.D.F (II) CON BROMURO DE CIANOGENO A REFLUJO DURANTE 16 HORAS; Y B) TRATAR A LA MEZCLA DE (A) CON UNA BASE FUERTE 6N COMO HIDROXIDO AMONICO, ENTRE 0 Y 50JC DURANTE 0,5 A 4 HORAS, PARA OBTENER UN C.D.F (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES DE ACIDOS INORGANICOS Y ORGANICOS. SIENDO: R1, H O ALQUILO DE C 1 A 4; R2 Y R4, H; R3 Y R5, H, ALQUILO DE C 1 A 6 Y OTROS; R6 Y R7 ALQUILO INFERIOR, FENILO Y OTROS; Y, H, ALQUILO DE C 1 A 4, HAL Y OTROS; Z -OR7; M Y N 1 A 6 (ENTEROS) Y C.D.F COMPUESTO DE FORMULA. SE UTILIZAN COMO ANTITROMBOTICOS E INHIBIR EL DESARROLLO DE TUMORES EN MAMIFEROS Y HUMANOS.
ES549920A 1984-02-15 1985-12-13 Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas Expired ES8606297A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58040984A 1984-02-15 1984-02-15

Publications (2)

Publication Number Publication Date
ES549920A0 ES549920A0 (es) 1986-04-16
ES8606297A1 true ES8606297A1 (es) 1986-04-16

Family

ID=24320992

Family Applications (2)

Application Number Title Priority Date Filing Date
ES540403A Expired ES8607299A1 (es) 1984-02-15 1985-02-14 Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES549920A Expired ES8606297A1 (es) 1984-02-15 1985-12-13 Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES540403A Expired ES8607299A1 (es) 1984-02-15 1985-02-14 Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas

Country Status (13)

Country Link
US (1) US4690925A (es)
EP (1) EP0153152A3 (es)
JP (1) JPS60193991A (es)
AU (1) AU581205B2 (es)
CA (1) CA1254557A (es)
DK (1) DK69285A (es)
ES (2) ES8607299A1 (es)
FI (1) FI81578C (es)
HU (2) HU191316B (es)
IL (1) IL74349A (es)
NO (1) NO164654C (es)
NZ (1) NZ211117A (es)
ZA (1) ZA851131B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
HU191316B (en) * 1984-02-15 1987-02-27 Syntex Usa Inc.,Us Process for producing (2-oxo-1,2,3,5-tetrahydro-imidazo /2,1-b/ quinazoline)-oxy-lakyl-amides and pharmacutical compositions containing them
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
EP0523513A1 (de) 1991-07-05 1993-01-20 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung substituierter Pyridazine zur Behandlung von Dermatosen
AU665207B2 (en) * 1991-07-29 1995-12-21 Warner-Lambert Company Quinazoline derivatives as acetylcholinesterase inhibitors
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31617A (en) * 1861-03-05 photo-uthcqfupheh
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
USRE31617E (en) 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US4313947A (en) * 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
US4070470A (en) * 1974-06-24 1978-01-24 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting carbostyrils, their compositions and method of use
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
NZ187452A (en) * 1977-06-10 1980-05-27 Otsuka Pharma Co Ltd N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
JPS54163825A (en) * 1978-06-15 1979-12-26 Otsuka Pharma Co Ltd Phosphoesterase inhibitor
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4551459A (en) * 1983-02-16 1985-11-05 Syntex (U.S.A.) Inc. Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
HU191316B (en) * 1984-02-15 1987-02-27 Syntex Usa Inc.,Us Process for producing (2-oxo-1,2,3,5-tetrahydro-imidazo /2,1-b/ quinazoline)-oxy-lakyl-amides and pharmacutical compositions containing them

Also Published As

Publication number Publication date
HU193409B (en) 1987-10-28
IL74349A0 (en) 1985-05-31
JPS60193991A (ja) 1985-10-02
NO850564L (no) 1985-08-16
ES549920A0 (es) 1986-04-16
NZ211117A (en) 1987-10-30
HUT36122A (en) 1985-08-28
HU191316B (en) 1987-02-27
DK69285D0 (da) 1985-02-14
CA1254557A (en) 1989-05-23
ES540403A0 (es) 1986-06-01
ES8607299A1 (es) 1986-06-01
DK69285A (da) 1985-08-16
EP0153152A3 (en) 1987-07-15
AU3875485A (en) 1985-08-22
FI81578B (fi) 1990-07-31
US4690925A (en) 1987-09-01
ZA851131B (en) 1986-09-24
FI850618A0 (fi) 1985-02-14
FI850618L (fi) 1985-08-16
NO164654B (no) 1990-07-23
NO164654C (no) 1990-10-31
IL74349A (en) 1988-07-31
EP0153152A2 (en) 1985-08-28
FI81578C (fi) 1990-11-12
AU581205B2 (en) 1989-02-16

Similar Documents

Publication Publication Date Title
ES8606297A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas
ATE94065T1 (de) Diazepine enthaltende pharmazeutische zusammensetzungen mit plaettchen aktivierender faktor (paf)-antagonistischer wirkung.
FI875059L (fi) Foereningar.
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
NZ212501A (en) Pyrazole analogs of mevalonolactone and pharmaceutical compositions
ATE45579T1 (de) Diazabicyclo-(3,3,1)-nonane.
ES452765A1 (es) Procedimiento para la preparacion de nuevos 2-tetrahidrofur-furil-6, 7-benzomorfanos disustituidos en 5,9-beta.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3480828D1 (de) Antivirale zusammensetzungen.
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo
ES8104812A1 (es) Un procedimiento para la preparacion de derivados de aceto- fenona substituidos
ES8604219A1 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES374291A1 (es) Un procedimiento para la preparacion de compuestos de 6,7- diaciloxi-tetrahidroisoquinoleinas.
DK422183A (da) Fremgangsmaade til fremstilling af 5-halogenvinyl-2'-deoxyuridinderivater
ES542393A0 (es) "4-(nitrofenil)-tetrahidropiridinas,procedimiento para su obtencion y su empleo como medicamento"
ES8707729A1 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
BG46152A3 (en) Herbicide composition
ES8505367A1 (es) Procedimiento para la preparacion de derivados de acridanona
ES8605241A1 (es) Procedimiento de preparacion de ftalidoisoquinolinas amina- das
ES2039273T3 (es) Compuestos antimicoticos a base de combinaciones de nicomicina y azol antimicotico.
ES8704477A1 (es) Procedimiento para preparar piridin-1-oxidos varias veces substituidos
FR2362842A1 (fr) Pyrimidinecarbonitriles herbicides
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
JPS5610173A (en) Analgesic
ES440252A1 (es) Procedimiento para la preparacion de dienilfosfatos.